Navigation Links
DHA Hailed as Breakthrough Treatment for Lowering Risk of Developmental Disorders in Premature Infants; Animi-3(R) Prescribed to Women Who Are Not Eating Fish
Date:1/19/2009

GORDONSVILLE, Va., Jan. 19 /PRNewswire/ -- Findings published in the Journal of the American Medical Association (JAMA) have demonstrated high doses of DHA-dominant omega-3 fatty acids administered to premature infants via their mother's breast milk can reduce the risk of developmental disorders.

In a six-year study involving 657 premature infants, researchers found the lipid DHA is not developed sufficiently in premature infants, leading to possible impaired mental development. To offset this omega-3 deficiency, 1000mg DHA supplements were given to lactating mothers with pre-term infants; some infants were fed supplemental infant formula with matching DHA levels.

Approximately 50 percent fewer infants on high-DHA diets experienced delayed mental development compared to infants on low-DHA diets. Infants weighing one-third the weight of a full-term baby who were fed high-DHA diets scored better on mental development tests, with a 40 percent reduction in the incidence of mild mental delay.

"My studies have shown that pregnant and lactating women are not eating fish, which is why a pharmaceutical-grade omega-3 supplement is so important to their daily diets," said Dr. Barbara Levine, Weill Cornell Medical College. "Since women are concerned about contaminants in fish and have difficulty stomaching fish during pregnancy, many doctors are now prescribing Animi-3, a DHA-dominant omega-3 formulation, to make sure they get what they need for baby."

"This new research published in JAMA supports the reasoning behind our prescription supplement with 350mg of DHA," said President Jack Schramm, PBM Pharmaceuticals, Inc., the makers of Animi-3. "Studies continue to highlight the role nutritional deficiencies of the Animi-3 nutrients play in the overall health of adults and their children."

Women are being prescribed Animi-3 by their doctors to address DHA and other nutritional deficiencies in their diets. Each capsule of Animi-3 contains 500 mg of omega-3, (350 mg of DHA), 200 mg of phytosterols, 1 mg of folic acid, 12.5 mg of B6, and 12 mcg of B12.

More information on Animi-3 ingredients is found on www.animi-3.com and on www.dhaandbvitamins.org, a resource developed by specialists at Weill Cornell Medical College and other medical centers.

Animi-3 is not intended to diagnose, treat, or cure any disease.

Source: JAMA. 2009;301(2):175-182

    Contact:  Joe Shields
    Director of Public Relations
    (800) 959-2066 ext. 1131
    jshields@pbmproducts.com


'/>"/>
SOURCE PBM Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. GRAS Proudly Announces Photometrica Version 2.0. Hailed as a Brilliant Solution for More Productive Astronomical Research by Those Engaged in Photometry Using the Global-Rent-a-scope Telescope Systems
2. Canine Cancer #1 Fear of Dog Lovers, Web Exclusive by Morris Animal Foundation Provides News on Latest Breakthroughs - Crucial Facts for Dog Owners
3. American Asthma Foundation Announces Breakthrough Discovery
4. A breakthrough in diagnosis of enteric lesions
5. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
6. DR. MIRACLES Wins 2008 WWD Beauty Biz Award: Breakthrough Product of the Year!!!
7. Res-Q Gains Rights To Market Orosine - a Breakthrough, Patented, Natural Heart Supplement That Cardiologists Are Calling the Ultimate Cardio Protection Against Heart Attacks, Strokes and Heart Failure.
8. 50th Annual Meeting of the American Society of Hematology Will Feature Breakthrough Research in Blood Diseases
9. Major North American breakthrough for dialysis patients
10. Canadian cold/flu breakthrough remedy undergoes NCI-sponsored trial in leukemia patients
11. Breakthrough in cell-type analysis offers new ways to study development and disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... and check-in, a cloud-based self-service technology that runs on the Posiflex XT-series of ... No. 1076 during HIMSS17 in Orlando, Florida. The terminal provider Posiflex ...
(Date:2/20/2017)... ... February 20, 2017 , ... Best Doctors® and IBM ... benefit for companies that want to help members of their workforce battling cancer. ... access to Watson’s suite of oncology offerings for insights on cancer treatment options, ...
(Date:2/20/2017)... ... February 20, 2017 , ... Chuck E. Cheese’s® and Center for ... joint event at Chuck E. Cheese’s locations throughout New England, New York and New ... opportunity to experience the fun of visiting Chuck E. Cheese’s in a sensory-friendly environment. ...
(Date:2/19/2017)... Van Wert, OH (PRWEB) , ... February 19, 2017 , ... ... known as The JEMS Conference & Exposition, the event will take place February 23-25, ... Utah. Braun Industries will be in Booth #909 with three new ambulances ...
(Date:2/18/2017)... Church, VA (PRWEB) , ... ... ... Culture of Change for Devicemakers , Sponsored by Axendia, **FDAnews Free Webinar**, ... , Are manufacturers looking to reduce their regulatory burden? Pay dividends ...
Breaking Medicine News(10 mins):
(Date:2/17/2017)... 2017 According to a new market research ... Counters), Application (Cleanroom Monitoring, Contamination Monitoring of Liquids), and End User ... MarketsandMarkets, the market is expected to reach USD 330.6 Million by ... 3.7% from 2016 to 2021. Continue ... ...
(Date:2/17/2017)... Feb. 17, 2017 Theravance Biopharma, Inc. ... the "Company") today announced the presentation of positive ... orally administered pan-Janus kinase (JAK) inhibitor designed to ... Congress of the European Crohn,s and Colitis Organization ... further data from its completed Phase 1 study ...
(Date:2/17/2017)... 17, 2017 Research and Markets has announced the ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
Breaking Medicine Technology: